Incorrect dosing can lead to inadequate glycaemic control or increased risk of adverse effects
potential long-term risks include pancreatitis, gallbladder disease, lean muscle loss, and early worsening of diabetic retinopathy, though no confirmed causal links exist beyond 48 weeks of data
Packer M, Zannad F, Butler J, Filippatos G, Ferreira JP, Pocock SJ, et al
flexible ratios Cycle driver Whichever compound titrates more slowly Cagrilintide Loading 0.25 2.4 mg over ~16 weeks Frequency Once weekly Maintenance 2.4 mg Route SubQ Semaglutide Loading 0.25 2.4 mg over ~16 weeks Frequency Once weekly Maintenance 2.4 mg Route SubQ Weekly Schedule Example (Maintenance) Same day each week Cagrilintide 2.4 mg SubQ + Semaglutide 2.4 mg SubQ Use separate syringes for each compound
By imitating this function, medications like semaglutide and tirzepatide trick your brain into thinking youre satisfied with smaller meal portions, which helps you maintain a calorie deficit (burning more calories than you consume) to lose weight
